01—Abstract
Summary
Summary of the 10-Q filed May 8, 2025. Cited figures are marked; the original filing is the authoritative source.
Corteva, Inc. reported a net income of $656 milliona for the first quarter of 2025, a significant increase from $423 million in the same period of the prior year.
This improvement was driven by higher income from continuing operations, which rose to $667 millionb from $376 million. Diluted earnings per share also saw a substantial increase, reaching $0.95 compared to $0.60 year-over-year. Net sales for the quarter were $4,417 million, a slight decrease of 2% compared to $4,492 million in Q1 2024.
This was primarily due to a 5% unfavorable currency impact, partially offset by a 2% increase in volume and a 1% increase in price. The company continues to navigate global economic conditions, including currency fluctuations, while focusing on operational efficiencies and strategic pricing. The company also returned approximately $385 millionc to shareholders through share repurchases and dividends.
02—Key points
Key Highlights
- Net income increased significantly by 55% to $656 million in Q1 2025, compared to $423 million in Q1 2024.
- Diluted EPS rose to $0.95 from $0.60 year-over-year, reflecting improved profitability.
- Net sales saw a slight decrease of 2% to $4,417 million, impacted by a 5% unfavorable currency effect, though volume and price showed modest growth.
- Operating EBITDA increased by 15% to $1,189 million, indicating strong operational performance and cost management.
- The company returned approximately $385 million to shareholders via dividends and share repurchases in the quarter.
- Corteva is undergoing a Crop Protection Operations Strategy Restructuring Program, expected to yield significant savings, with substantial charges already incurred.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed May 8, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $4.42B$4.49B | −1.7% |
| Cost of Revenue | $2.34B$2.55B | −8.2% |
| Gross Profit | $2.08B$1.94B | +6.8% |
| R&D Expenses | $335.00M$332.00M | +0.9% |
| SG&A Expenses | $751.00M$736.00M | +2.0% |
| Net Income | $656.00M$423.00M | +55.1% |
| EPS (Basic) | $0.95$0.60 | +58.3% |
| EPS (Diluted) | $0.95$0.60 | +58.3% |
| Shares Outstanding (Basic) | 684.90M700.40M | −2.2% |
| Shares Outstanding (Diluted) | 686.60M702.80M | −2.3% |
05—Questions
Frequently Asked Questions
What was the primary driver of the increase in net income?
The primary driver for the increase in net income was higher income from continuing operations, which benefited from improved operational efficiencies, cost and productivity actions, and favorable product mix, partially offset by unfavorable currency impacts.
How did currency fluctuations impact the company's financial performance?
Currency fluctuations had a negative impact on net sales, with a 5% unfavorable currency impact noted. This was primarily driven by the weakening of the Brazilian Real, Turkish Lira, and Euro against the US Dollar. However, favorable currency effects did contribute to lower cost of goods sold.
What is the status of the Crop Protection Operations Strategy Restructuring Program?
The Crop Protection Operations Strategy Restructuring Program is ongoing. Through the first quarter of 2025, the company had recorded $487 million in net pre-tax charges related to this program. The program is expected to be substantially complete by the end of 2026 and is projected to contribute an estimated $180 million in run-rate savings by 2027.
How is Corteva returning capital to shareholders?
Corteva is returning capital to shareholders through share repurchase programs and common stock dividends. In the first quarter of 2025, approximately $385 million was returned to shareholders through these methods. The company has active share repurchase programs totaling $3 billion and $2 billion.
06—Continue